SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-058214
Filing Date
2023-12-19
Accepted
2023-12-18 18:07:01
Documents
12
Period of Report
2023-12-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ef20016865_8k.htm   iXBRL 8-K 32437
  Complete submission text file 0001140361-23-058214.txt   170907

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kron-20231218.xsd EX-101.SCH 3869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20231218_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20231218_pre.xml EX-101.PRE 16047
6 EXTRACTED XBRL INSTANCE DOCUMENT ef20016865_8k_htm.xml XML 4227
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 231495033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)